RxDoctor Payments Data

Heather Garrett

Nurse Practitioner · Killen, ALNPI 1316144264

Payments from drug & device makers

$1,951in general payments, 2019–2025

Across 131 payments — averaging $14.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$556
  • Lilly USA, LLC$395
  • AbbVie$305
  • AstraZeneca$247
  • GSK$110
  • Pfizer$56
  • plus $282 from 11 others

What the payments were for

  • Food & beverage$1,94099%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,951 in reported general payments places this provider in the 80th percentile of 1,505 nurse practitioner providers in Alabama.

See all nurse practitioner providers in Alabama

Medicare billing

Part B allowed, 2024
$72,005
Medicare patients
195
Services billed
2,813

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide56$69,285
OzempicSemaglutide49$63,801
EliquisApixaban46$50,637
FarxigaDapagliflozin Propanediol54$46,414
RybelsusSemaglutide26$35,397
Trelegy ElliptaFluticasone/Umeclidin/Vilanter45$32,776
JardianceEmpagliflozin22$19,965
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,795
LinzessLinaclotide16$8,231
SynjardyEmpagliflozin/Metformin Hcl12$7,146
Tresiba Flextouch U-200Insulin Degludec11$7,052
Esomeprazole Magnesium72$4,973
Levothyroxine Sodium237$2,740
Duloxetine Hcl117$2,501
Atorvastatin Calcium221$2,140

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$556$99,19875 claims
Lilly USA, LLCMounjaro$395$69,28556 claims
AstraZenecaFarxiga, Breztri Aerosphere$247$55,20968 claims
PfizerEliquis$56$50,63746 claims
GSKTrelegy Ellipta$110$32,77645 claims
Boehringer IngelheimJardiance, Synjardy$56$27,11134 claims
AbbVieLinzess$305$8,23116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,505 nurse practitioner providers in Alabama.

Other nurse practitioner in Killen

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →